Obsessive Compulsive Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Obsessive Compulsive Disorder stocks.

Recent Signals

Date Stock Signal Type
2021-04-09 ALKS 200 DMA Support Bullish
2021-04-09 ALKS Bollinger Band Squeeze Range Contraction
2021-04-09 ALKS MACD Bullish Signal Line Cross Bullish
2021-04-09 JAZZ Doji - Bullish? Reversal
2021-04-09 JAZZ Lizard Bullish Bullish Day Trade Setup
2021-04-09 JAZZ Stochastic Buy Signal Bullish
2021-04-09 LLY MACD Bullish Signal Line Cross Bullish
2021-04-09 MDT New 52 Week Closing High Bullish
2021-04-09 MDT 180 Bullish Setup Bullish Swing Setup

Recent News for Obsessive Compulsive Disorder Stocks

Date Stock Title
Apr 10 LLY The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 10 LLY Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline?
Apr 9 JAZZ Jazz Securities Designated Activity Company -- Moody's assigns Ba2 to Jazz Pharma's new secured credit facilities; negative outlook
Apr 9 LLY Top Stock Reports for Oracle, Eli Lilly & BP
Apr 9 LLY Lilly's (LLY) JAK Inhibitor Olumiant Fails COVID-19 Study
Apr 9 LLY Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes
Apr 9 LLY NIH recommends Lilly and Regeneron's combination antibody treatments to people with mild and moderate COVID-19
Apr 9 LLY Provention Bio Shares Crash 40% Due To Regulatory Setback For Diabetes Drug
Apr 9 LLY The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
Apr 9 LLY Provention Bio Stock Craters After FDA Flags Deficiencies In PK Profiles From Teplizumab Trials For Diabetes
Apr 8 LLY Lilly woes provide buying opportunity, Danaher a buy with likely earnings beat, and more in today's analyst action
Apr 8 ALKS Alkermes (ALKS) Inks Deal With Merck for Ovarian Cancer Study
Apr 8 LLY Eli Lilly-Incyte's Baricitinib Study In Hospitalized COVID-19 Patients Fails To Meet Main Goal
Apr 8 LLY Lilly, Incyte's COV-BARRIER study fails to meet primary endpoint in COVID-19
Apr 8 LLY Eli Lilly and Incyte say Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal
Apr 8 LLY Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients
Apr 7 ALKS Alkermes and Merck team up for late-stage ovarian cancer study
Apr 7 MDT Medtronic (MDT) Hits New 52-Week High: What's Driving It?
Apr 7 MDT Medtronic Announces Ongoing Initiatives to Address Health Equity for People of Color Living with Diabetes
Apr 7 MDT The Medtronic Foundation and Children's Heartlink Focus New Partnership on Health Equity for 10,000 Children and 10,000 Health Workers in Underserved Countries

Obsessive–compulsive disorder (OCD) is a mental disorder where people feel the need to check things repeatedly, perform certain routines repeatedly (called "rituals"), or have certain thoughts repeatedly (called "obsessions"). People are unable to control either the thoughts or the activities for more than a short period of time. Common activities include hand washing, counting of things, and checking to see if a door is locked. Some may have difficulty throwing things out. These activities occur to such a degree that the person's daily life is negatively affected. This often takes up more than an hour a day. Most adults realize that the behaviors do not make sense. The condition is associated with tics, anxiety disorder, and an increased risk of suicide.The cause is unknown. There appear to be some genetic components with both identical twins more often affected than both non-identical twins. Risk factors include a history of child abuse or other stress-inducing event. Some cases have been documented to occur following infections. The diagnosis is based on the symptoms and requires ruling out other drug related or medical causes. Rating scales such as the Yale–Brown Obsessive Compulsive Scale (Y-BOCS) can be used to assess the severity. Other disorders with similar symptoms include anxiety disorder, major depressive disorder, eating disorders, tic disorders, and obsessive–compulsive personality disorder.Treatment involves counseling, such as cognitive behavioral therapy (CBT), and sometimes antidepressants such as selective serotonin reuptake inhibitors (SSRIs) or clomipramine. CBT for OCD involves increasing exposure to what causes the problems while not allowing the repetitive behavior to occur. While clomipramine appears to work as well as SSRIs, it has greater side effects so is typically reserved as a second line treatment. Atypical antipsychotics may be useful when used in addition to an SSRI in treatment-resistant cases but are also associated with an increased risk of side effects. Without treatment, the condition often lasts decades.Obsessive–compulsive disorder affects about 2.3% of people at some point in their life. Rates during a given year are about 1.2%, and it occurs worldwide. It is unusual for symptoms to begin after the age of 35, and half of people develop problems before 20. Males and females are affected about equally. In English, the phrase obsessive–compulsive is often used in an informal manner unrelated to OCD to describe someone who is excessively meticulous, perfectionistic, absorbed, or otherwise fixated.

More about Obsessive Compulsive Disorder
Browse All Tags